Pneumococcal Infections: all 286 studies
Page 3 of 3. Open to participants first (27), then studies with results posted, then the rest; newest registration first within each.
- Sequential Versus Simultaneous Pneumococcal Vaccination in Elderly: Immunological Memory and Antibody LevelsCompletedNCT02637583Phase 4
- Safety, Tolerability, Efficacy and Pharmacodynamics of CAL02 in Severe Pneumonia Caused by Streptococcus PneumoniaeCompletedNCT02583373Phase 1
- Influenza Vaccine and Pneumococcal VaccineCompletedNCT02582047Phase 4
- A Phase I Study to Evaluate the Safety and Immunogenicity of PnuBioVaxCompletedNCT02572635Phase 1
- Vaccination Impact Against Pneumococcal Disease on Acute Otitis Media Morbidity in Colombian Children < 5 Years of AgeCompletedNCT02567747
- Pneumonia Vaccine in Aging HIV Positive IndividualsCompletedNCT02558751Early Phase 1
- Immune Response to Pneumococcal Vaccination in HIV Infected IndividualsCompletedNCT02515240Early Phase 1
- Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated VasculitisStatus unknownNCT02463578
- Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated VasculitisCompletedNCT02463539
- Safety and Immunogenicity Study of 23-valent Pneumococcal Polysaccharide Vaccine in Healthy Children, Adults and ElderlyCompletedNCT02451969Phase 3
- Antibodies and Memory Cells Role After Different Pneumococcal Vaccines in HIV AdultsWithdrawnNCT02357823
- Safety and Immunogenicity of a Newly 23-valent Pneumococcal Polysaccharide Vaccine in Chinese Adults and ChildrenCompletedNCT02285036Phase 3
- Open Randomized Trial Evaluating Four Anti-pneumococcal Vaccine Strategies With Fractionated Doses of Non Conjugate Polysaccharide Vaccine to Prevent Hyporesponse in Healthy VolunteersCompletedNCT02279589Phase 2
- Immunogenicity Study of an Anti-pneumococcal Vaccination Strategy in Patients With Sickle Cells DiseaseCompletedNCT02274415Phase 2
- Anti-pneumococcal Vaccine Strategy in Patients Treated With Immunosuppressants or Biotherapies for CIBDTerminatedNCT02255227Phase 2
- MF59-adjuvanted Influenza Vaccine and 23-valent Pneumococcal Polysaccharide VaccineCompletedNCT02225327Phase 4
- Immunogenicity and Safety Study of NBP606 in Healthy InfantsCompletedNCT02201030Phase 3
- Identifocation the B Cell Subsets Responsible for Anti-pneumococcal ResponseCompletedNCT02126384Not applicable
- Serological Response to Antipneumococcal Vaccination and Impact on Streptococcus Pneumoniae Nasal Carriage in HIV AdultsCompletedNCT02123433Phase 3
- Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. PneumoniaeCompletedNCT02116998Phase 2
- Study Immunogenicity and Safety of 13-valent Pneumococcal Conjugate VaccineCompletedNCT02079207Phase 3
- Study of Evaluating Safety and Immunogenicity of 23-Valent Pneumococcal Polysaccharide Vaccine With Influenza Vaccine in Children and AdultsCompletedNCT02062281Phase 4
- Multicenter Pilot Study Evaluating the Immunogenicity of an Innovative Pneumococcal Vaccination Strategy in Splenectomized AdultsCompletedNCT02052154Phase 2
- Mechanisms of Impaired HIV-associated B Cell and Pneumococcal Vaccine ResponsesStatus unknownNCT02012309Not applicable
- An Incitative Multifaceted PROcedure for Pneumococcal Vaccination at the Emergency DepartmentCompletedNCT01899365
- Hepatitis B Vaccination in InfantsCompletedNCT01896596Phase 4
- Aerosolized and Intravenous Colistin in Healthy AdultsTerminatedNCT01863719Phase 1
- Serotype Distribution of Streptococcus Pneumoniae That Causes Invasive Diseases at Children and Adults in TurkeyCompletedNCT01810861
- Study to Evaluate Safety, Reactogenicity and Immunogenicity of the Pneumococcal Protein PhtD Vaccine in Healthy AdultsCompletedNCT01767402Phase 1
- Impact of Introduction of PHiD-CV for Nunavik Children, Quebec, CanadaStatus unknownNCT01694329
- A Study Evaluating 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) In Healthy Infants In ChinaCompletedNCT01692886Phase 3
- Immunogenicity and Reactogenicity of PCV13 Among Infants and Children in Burkina FasoCompletedNCT01577771Phase 4
- Serotype Distribution of Chest X-ray Confirmed Pneumococcal Community Acquired Pneumonia in the Adult Population in Greece, Over 1 Year.CompletedNCT01564771
- A Study Assessing 13-valent Pneumococcal Conjugate Vaccine in Healthy Chinese SubjectsCompletedNCT01531322Phase 1
- Study of Investigational Pneumococcal Vaccine in Healthy Adults, Toddlers and InfantsCompletedNCT01446926Phase 1
- Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy AdultsCompletedNCT01444352Phase 1
- Study of Two Investigational Pneumococcal Vaccines in Healthy AdultsCompletedNCT01444339Phase 1
- Study of an Investigational Pneumococcal Vaccine in Healthy Adult VolunteersCompletedNCT01444001Phase 1
- Evaluating the Safety and Immune Response to Two Pneumococcal Vaccines in HIV-Infected Pregnant WomenWithdrawnNCT01443117Phase 2
- Pneumococcal Adult Kinetics Study - Understanding the B Cell Response to Pneumococcal VaccinesCompletedNCT01432158Phase 3
- The Role of Reactive Thrombocytosis in Children With Pneumococcal InfectionCompletedNCT01194349
- Study Estimating the Impact of Prevnar 13™ (13vPnC) on Invasive Pneumococcal DiseaseCompletedNCT01128439
- Child Pneumococcal Serotype Epidemiology In GreeceCompletedNCT01111214
- 13 Valent Pneumococcal Conjugate Vaccine - Follow-on StudyCompletedNCT01095471Phase 4
- Impact of PCV on Disease and Colonization Among Native American CommunitiesCompletedNCT01083459
- A Study to Assess the Impact of Pneumococcal Conjugate Vaccination Programme on the Carriage of PneumococciCompletedNCT01040143
- 7-valent Pneumococcal Conjugated VaccinationStatus unknownNCT00885625Phase 4
- Open-Label Study Assessing The Safety, Immunogenicity and Dose Response of IC47CompletedNCT00873431Phase 1
- A Retrospective Epidemiological Study on Pneumococcal Infection in Children in Ministry of Health Hospital at EHSA Region in the Eastern ProvinceStatus unknownNCT00844467
- Multicenter Prospective Evaluation of the Incidence and Serotyes of Invasive Pneumoccocal Disease (IPD) Among Children Below 5 YearsStatus unknownNCT00843895Not applicable
- Disease Burden of Pneumonia, Meningitis and Bacteremia Among Children in Japan: Pneumonet JapanCompletedNCT00757575
- PneuMum: Pneumococcal Vaccination of Australian Indigenous MothersCompletedNCT00714064Phase 3
- Study to Evaluate the Immune Response of United Kingdom (UK) Infants Receiving DTaP/Hib/IPV, Meningococcal C Conjugate and Pneumococcal Conjugate Vaccines, Antibody Persistence and Responses to Booster Doses in the Second Year of LifeCompletedNCT00625677Phase 4
- Safety and Immunogenicity Study of MenC-TT Vaccine (NeisVac-C) in Toddlers Previously Immunized With PCV7 (Prevenar®)CompletedNCT00617760Phase 3
- Safety, Tolerability and Immunogenicity of Pneumovax 23 in Healthy Adults in India (V110-011)CompletedNCT00496093Phase 3
- Safety and Local Tolerability of Prevenar in Indian ChildrenCompletedNCT00488800
- Study Evaluating Streptococcus Pneumoniae Nasopharyngeal Carriage Rate in Children Receiving Prevnar®CompletedNCT00488371
- Pneumococcal Reference StandardCompletedNCT00479323Phase 1
- Pneumoniae Epidemiology Study in ChinaCompletedNCT00471770
- Efficacy Trial of Two Pneumococcal Conjugate Vaccines (PncCRM and PncOMPC) for Prevention of Acute Otitis Media Due to Vaccine SerotypesCompletedNCT00378417Phase 3
- Immunogenicity of 7-Valent Pneumococcal Conjugate Vaccine in Lung Fluid of Adults With and Without HIV InfectionCompletedNCT00371878Phase 4
- Immunogenicity and Safety Study of Pneumococcal 7-Valent Conjugate Vaccine in Sickle Cell Disease Infants.TerminatedNCT00368186Phase 4
- Safety and Immune Response Study of an Investigational Pneumococcal Vaccine.CompletedNCT00327522Phase 2
- PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it Protects Their Babies From Ear DiseaseStatus unknownNCT00310349Phase 3
- Safety and Efficacy Study of Investigational Pneumococcal Vaccine in Elderly PopulationCompletedNCT00307528Phase 2
- Humoral Determinants of Immunity to Pneumococcal InfectionCompletedNCT00304382Phase 4
- Long-term Impact of Pneumococcal Conjugate Vaccine on CarriageCompletedNCT00294021
- Study Evaluating Prevenar Vaccine in Healthy InfantsCompletedNCT00276107Phase 4
- Immunogenicity of PCV-7 Vaccine in VLBW InfantsCompletedNCT00273325
- Study Evaluating Prevenar in High-Risk ChildrenCompletedNCT00234338
- Racial Disparities in Pneumococcal Vaccination in Managed CareCompletedNCT00229762Not applicable
- Study Evaluating Prevenar in the Prevention of Invasive Pneumococcal Disease (IPD) in the Paediatric Population in Spain.CompletedNCT00227188
- Response of United Kingdom (UK) Infants to a Reduced Primary Schedule With Meningococcal C and Pneumococcal Conjugate VaccinesCompletedNCT00197808Phase 4
- Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis MediaCompletedNCT00195611
- Study Investigating Administration of Prevenar for Post-Marketing SurveillanceCompletedNCT00195390
- Effect of Two Versus Three Pneumococcal Conjugate VaccinationsCompletedNCT00189020Phase 3
- Pneumococcal Vaccination of Fiji InfantsCompletedNCT00170612Phase 2
- Pneumococcal Conjugate Vaccine With Pneumococcal Polysaccharide Vaccine and Tetanus/Diphtheria VaccineCompletedNCT00164411Phase 1
- Mother's Gift ProjectCompletedNCT00142389Phase 1/2
- Early Versus Delayed Pneumococcal Vaccination in HIVCompletedNCT00137605Phase 1/2
- 9-valent CRM 197 PneumococcalCompletedNCT00133549Phase 2
- A Study of V110 a Pneumococcal Vaccine in Healthy Adults (V110-013)CompletedNCT00127153Phase 3
- Safety of and Immune Response to a Pneumococcal Vaccine (PncCV) in HIV Infected and Uninfected ChildrenStatus unknownNCT00099658Not applicable
- Pneumococcal Vaccine and Routine Pediatric Immunizations in HIV-Infected Children Receiving Anti-HIV DrugsCompletedNCT00013871Not applicable
- Effects of MAC Preventive Therapy on Disease-Causing Bacteria in HIV-Infected Patients: A Substudy of CPCRA 048CompletedNCT00000933
- A Double-Blind Placebo-Controlled Trial of the Safety and Immunogenicity of a Seven Valent Pneumococcal Conjugate Vaccine in Presumed HIV-Infected InfantsCompletedNCT00000829Phase 1